427 related articles for article (PubMed ID: 30717573)
21. The Role of Adjuvant Therapy in the Management of Chronic Urticaria.
Keumala Budianti W; Mahri S; Almira D
Actas Dermosifiliogr; 2023 Jun; 114(6):T523-T530. PubMed ID: 37172893
[TBL] [Abstract][Full Text] [Related]
22. The Role of Adjuvant Therapy in the Management of Chronic Urticaria.
Keumala Budianti W; Mahri S; Almira D
Actas Dermosifiliogr; 2023 Jun; 114(6):523-530. PubMed ID: 36871821
[TBL] [Abstract][Full Text] [Related]
23. Omalizumab in Chronic Spontaneous Urticaria: A Brazilian Real-Life Experience.
Ensina LF; Valle SO; Juliani AP; Galeane M; Vieira dos Santos R; Arruda LK; Melo JM; de Souza PK; Serpa FS; de Andrade DM; França AT; Campos RA; Camelo-Nunes I; Solé D
Int Arch Allergy Immunol; 2016; 169(2):121-4. PubMed ID: 27055122
[TBL] [Abstract][Full Text] [Related]
24. Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy.
Casale TB; Bernstein JA; Maurer M; Saini SS; Trzaskoma B; Chen H; Grattan CE; Gimenéz-Arnau A; Kaplan AP; Rosén K
J Allergy Clin Immunol Pract; 2015; 3(5):743-50.e1. PubMed ID: 26054553
[TBL] [Abstract][Full Text] [Related]
25. Clinical Characteristics, Investigations and Treatment in Children with Chronic Urticaria: An Observational Study.
Buono EV; Giannì G; Scavone S; Caffarelli C
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792886
[No Abstract] [Full Text] [Related]
26. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M
Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957
[TBL] [Abstract][Full Text] [Related]
27. Comparison between chronic spontaneous urticaria and chronic induced urticaria on the efficacy of omalizumab treatment: A systematic review and meta-analysis.
He ZH; Qiu SC; Huang ZW; Zhang GQ; An QQ; Qu F; Wang N
Dermatol Ther; 2022 Dec; 35(12):e15928. PubMed ID: 36222320
[TBL] [Abstract][Full Text] [Related]
28. A patient-oriented approach to long-term use of omalizumab in chronic spontaneous urticaria.
Ornek S; Kocaturk E
Cutan Ocul Toxicol; 2021 Dec; 40(4):305-311. PubMed ID: 34212792
[TBL] [Abstract][Full Text] [Related]
29. Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn's Disease.
Barni S; Giovannini M; Liccioli G; Sarti L; Gissi A; Lionetti P; Mori F
Front Immunol; 2021; 12():635069. PubMed ID: 33737936
[TBL] [Abstract][Full Text] [Related]
30. Dramatic improvement with colchicine in antihistamine- and omalizumab-resistant chronic spontaneous urticaria.
Abe N; Bohgaki M; Kasahara H
Clin Exp Dermatol; 2022 Dec; 47(12):2308-2310. PubMed ID: 36052842
[TBL] [Abstract][Full Text] [Related]
31. Real-life, long-term data on efficacy, safety, response and discontinuation patterns of omalizumab in a Greek population with chronic spontaneous urticaria.
Apalla Z; Sidiropoulos T; Kampouropoulou E; Papageorgiou M; Lallas A; Lazaridou E; Smaragdi M; Delli F
Eur J Dermatol; 2020 Dec; 30(6):716-722. PubMed ID: 33258453
[TBL] [Abstract][Full Text] [Related]
32. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data.
Salman A; Demir G; Bekiroglu N
Dermatol Ther; 2019 Jul; 32(4):e12975. PubMed ID: 31145524
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H
Chu CY; Al Hammadi A; Agmon-Levin N; Atakan N; Farag A; Arnaout RK; Kannenberg S; Kulthanan K; Mubarak A; Zaitoun F; Crowe S; Malfait S; Cooke K; Dekker EL
World Allergy Organ J; 2020 Apr; 13(4):100117. PubMed ID: 32382379
[TBL] [Abstract][Full Text] [Related]
34. Consensus on the diagnostic and therapeutic management of chronic spontaneous urticaria in adults - Brazilian Society of Dermatology.
Criado PR; Maruta CW; Alchorne AOA; Ramos AMC; Gontijo B; Santos JBD; Martins LEAM; Rivitti-Machado MC; Silvares MRC; Pires MC; Souza PK; Orfali RL; Bonamigo RR; Bedrikow RB; Criado RFJ; Oliveira ZNP
An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):56-66. PubMed ID: 31166404
[TBL] [Abstract][Full Text] [Related]
35. Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria.
Magen E; Waitman DA; Kahan NR
Allergy Asthma Proc; 2021 Jan; 42(1):e17-e24. PubMed ID: 33404397
[No Abstract] [Full Text] [Related]
36. Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don't Know.
Terhorst-Molawi D; Fox L; Siebenhaar F; Metz M; Maurer M
Am J Clin Dermatol; 2023 May; 24(3):397-404. PubMed ID: 36810982
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of drug therapies in antihistamine refractory chronic spontaneous urticaria: Real life data.
Unsel M
Asian Pac J Allergy Immunol; 2024 Jun; 42(2):138-146. PubMed ID: 33638629
[TBL] [Abstract][Full Text] [Related]
38. Current and future therapies for treating chronic spontaneous urticaria.
Maurer M; Vena GA; Cassano N; Zuberbier T
Expert Opin Pharmacother; 2016 Jun; 17(8):1131-9. PubMed ID: 26918673
[TBL] [Abstract][Full Text] [Related]
39. Omalizumab in the Treatment of Chronic Urticaria: The Effect of Drug Co-Administration and Co-Morbidities.
Tagka A; Lambrou GI; Nicolaidou E; Nakou E; Makris M; Stratigos A; Katsarou A
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(1):39-50. PubMed ID: 32013838
[TBL] [Abstract][Full Text] [Related]
40. A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real-world study in Belgium.
Lapeere H; Baeck M; Stockman A; Sabato V; Grosber M; Moutschen M; Lambert J; Vandebuerie L; de Montjoye L; Rabijns H; Allewaert K; Schrijvers R
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):127-134. PubMed ID: 31099916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
